New concepts in necrotizing enterocolitis

Current Opinion in Pediatrics

Volumn 13, Issue 2, 2001, Pages 111-115

  Caplan, Michael S ^a   Jilling, Tamas ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; ERYTHROPOIETIN RECEPTOR; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 8; INTESTINAL TREFOIL FACTOR; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; SCATTER FACTOR;

ABDOMINAL DRAINAGE; ANEMIA; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; BREAST FEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; INTESTINE TRANSPLANTATION; LAPAROTOMY; NECROTIZING ENTERITIS; NEWBORN; NEWBORN DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; RAT; REVIEW; RISK FACTOR;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; RISK FACTORS;

EID: 0035028853     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200104000-00004     Document Type: Review

References (45)

1. Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates
2. Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding
3. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial
4. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants
5. Severity of necrotizing enterocolitis: Influence on outcome at 2 years of age
6. Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis
7. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994
8. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: A pilot study
9. Magnetic resonance imaging of intestinal necrosis in preterm infants
10. Preventing necrotizing enterocolitis in neonates
11. The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation
12. Randomized trial of slow versus fast feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants
13. Feeding strategies for premature infants: Randomized trial of gastrointestinal priming and tube-feeding method
14. Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure
15. Morbidity of low-birthweight infants with intrauterine cocaine exposure
16. Maternal cocaine abuse resulting in necrotizing enterocolitis. An experimental study in a rat model. II. Results of perfusion studies
17. Necrotising enterocolitis: Is there a relationship to specific pathogens?
18. Stool microflora in extremely low birthweight infants
19. Models of the pathogenesis of necrotizing enterocolitis
20. Breast milk and the prevention of neonatal and preterm gastrointestinal disease states: A new perspective
21. Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis
22. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats
23. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis
24. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates
25. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight
26. Effects of epidermal growth factor and Clostridium difficile toxin B in a model of mucosal injury
27. Diminished epidermal growth factor levels in infants with necrotizing enterocolitis
28. Hepatocyte growth factor in human milk and reproductive tract fluids
29. Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells
30. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis
31. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis
32. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat
33. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis
34. Recombinant human interleukin-11 prevents mucosal atrophy and bowel shortening in the defunctionalized intestine
35. The trefoil peptide family
36. Expression of intestinal trefoil factor in developing rat intestine
37. Prostanoids mediate the protective effect of trefoil factor 3 in oxidant-induced intestinal epithelial cell injury: Role of cyclooxygenase-2
38. Breast milk and neonatal necrotising enterocolitis
39. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids
40. Regulatory effects of bifidobacteria on the growth of other colonic bacteria
41. Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model
42. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria
43. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit
44. Salvage laparotomy for failure of peritoneal drainage in necrotizing enterocolitis in infants with extremely low birth weight
45. Intestinal transplantation for short gut syndrome attributable to necrotizing enterocolitis